Back to Search Start Over

CRISPR/Cas9 mediated GFP-human dentin matrix protein 1 (DMP1) promoter knock-in at the ROSA26 locus in mesenchymal stem cell for monitoring osteoblast differentiation.

Authors :
Shahabipour F
Oskuee RK
Shokrgozar MA
Naderi-Meshkin H
Goshayeshi L
Bonakdar S
Source :
The journal of gene medicine [J Gene Med] 2020 Dec; Vol. 22 (12), pp. e3288. Date of Electronic Publication: 2020 Oct 29.
Publication Year :
2020

Abstract

Background: Dentin matrix protein 1 (DMP1) is highly expressed in mineralized tooth and bone, playing a critical role in mineralization and phosphate metabolism. One important role for the expression of DMP1 in the nucleus of preosteoblasts is the up-regulation of osteoblast-specific genes such as osteocalcin and alkaline phosphatase <superscript>1</superscript> . The present study aimed to investigate the potential application of human DMP1 promoter as an indicator marker of osteoblastic differentiation.<br />Methods: In the present study, we developed DMP1 promoter-DsRed-GFP knock-in mesenchymal stem cell (MSCs) via the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system that enabled automatic detection of osteoblast differentiation. With the application of a homology-directed knock-in strategy, a 2-kb fragment of DMP1 promoter, which was inserted upstream of the GFP and DsRed reporter cassette, was integrated into the human ROSA locus to generate double fluorescent cells. We further differentiated MSCs under osteogenic media to monitor the fate of MSCs. First, cells were transfected using CRISPR/Cas9 plasmids, which culminated in MSCs with a green fluorescence intensity, then GFP-positive cells were selected using puromycin. Second, the GFP-positive MSCs were differentiated toward osteoblasts, which demonstrated an increased red fluorescence intensity. The osteoblast differentiation of MSCs was also verified by performing alkaline phosphatase and Alizarin Red assays.<br />Results: We have exploited the DMP1 promoter as a predictive marker of MSC differentiation toward osteoblasts. Using the CRISPR/Cas9 technology, we have identified a distinctive change in the fluorescence intensities of GFP knock-in (green) and osteoblast differentiated MSCs <superscript>2</superscript> .<br />Conclusions: The data show that DMP1-DsRed-GFP knock-in MSCs through CRISPR/Cas9 technology provide a valuable indicator for osteoblast differentiation. Moreover, The DMP1 promoter might be used as a predictive marker of MSCs differentiated toward osteoblasts.<br /> (© 2020 John Wiley & Sons, Ltd.)

Details

Language :
English
ISSN :
1521-2254
Volume :
22
Issue :
12
Database :
MEDLINE
Journal :
The journal of gene medicine
Publication Type :
Academic Journal
Accession number :
33047833
Full Text :
https://doi.org/10.1002/jgm.3288